Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Balzarini

Showing results (461-470 of 563) with videos related to

Pageof 57
Sort By:
Journal of Medicinal Chemistry|May 18, 2001
Ether phospholipid-AZT conjugates possessing anti-HIV and antitumor cell activity. Synthesis, conformational analysis, and study of their thermal effects on membrane bilayersT Mavromoustakos, T Calogeropoulou, M Koufaki, et al.
Biochemical Pharmacology|April 1, 1988
Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyribosideR Pauwels, M Baba, J Balzarini, et al.
Cancer Gene Therapy|April 19, 2000
Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinaseC Grignet-Debrus, V Cool, N Baudson, et al.
Journal of Medicinal Chemistry|November 25, 1994
1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activityR Alvarez, S Velázquez, A San-Félix, et al.
Nucleosides & Nucleotides|August 5, 1999
Prodrugs of Ara-CMP and Ara-AMP with a S-acyl-2-thioethyl (SATE) biolabile phosphate protecting group: synthesis and biological evaluationR Bazzanini, S Manfredini, E Durini, et al.
Molecular Pharmacology|August 1, 1996
Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokinesC F Perno, E Balestra, S Aquaro, et al.
Biochemical Pharmacology|June 1, 1987
Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivityD A Cooney, G Ahluwalia, H Mitsuya, et al.
Antiviral Research|August 1, 1997
Phosphoramidate derivatives of d4T as inhibitors of HIV: the effect of amino acid variationC McGuigan, H W Tsang, D Cahard, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Bicyclic anti-VZV nucleosides: Thieno analogues retain full antiviral activityA Brancale, C McGuigan, B Algain, et al.
Antiviral Research|June 9, 2001
Exploring the role of the 5'-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivativesC Chamorro, M J Pérez-Pérez, F Rodríguez-Barrios, et al.
Pageof 57

Showing results (461-470 of 563) with videos related to

Sort By:
Pageof 57
Journal of Medicinal Chemistry|May 18, 2001
Ether phospholipid-AZT conjugates possessing anti-HIV and antitumor cell activity. Synthesis, conformational analysis, and study of their thermal effects on membrane bilayersT Mavromoustakos, T Calogeropoulou, M Koufaki, et al.
Biochemical Pharmacology|April 1, 1988
Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyribosideR Pauwels, M Baba, J Balzarini, et al.
Cancer Gene Therapy|April 19, 2000
Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinaseC Grignet-Debrus, V Cool, N Baudson, et al.
Journal of Medicinal Chemistry|November 25, 1994
1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activityR Alvarez, S Velázquez, A San-Félix, et al.
Nucleosides & Nucleotides|August 5, 1999
Prodrugs of Ara-CMP and Ara-AMP with a S-acyl-2-thioethyl (SATE) biolabile phosphate protecting group: synthesis and biological evaluationR Bazzanini, S Manfredini, E Durini, et al.
Molecular Pharmacology|August 1, 1996
Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokinesC F Perno, E Balestra, S Aquaro, et al.
Biochemical Pharmacology|June 1, 1987
Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivityD A Cooney, G Ahluwalia, H Mitsuya, et al.
Antiviral Research|August 1, 1997
Phosphoramidate derivatives of d4T as inhibitors of HIV: the effect of amino acid variationC McGuigan, H W Tsang, D Cahard, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Bicyclic anti-VZV nucleosides: Thieno analogues retain full antiviral activityA Brancale, C McGuigan, B Algain, et al.
Antiviral Research|June 9, 2001
Exploring the role of the 5'-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivativesC Chamorro, M J Pérez-Pérez, F Rodríguez-Barrios, et al.
Pageof 57